Vaxcyte Inc share price logo

Vaxcyte Inc Share Price

NASDAQ: PCVX

Mid Cap

$32.18

-0.88

(-2.66%)

as on

Vaxcyte Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $31.77
    $32.88
    downward going graph

    1.27%

    Downside

    2.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $27.66
    $121.06
    downward going graph

    14.05%

    Downside

    276.18%

    Upside

    downward going graph

Vaxcyte Inc share price movements today

Previous Close
$33.06
Open
$32.60
Volume
1.1M
Day's Low - High
$31.77 - $32.88
52 Week Low - High
$27.66 - $121.06

Vaxcyte Inc Historical Returns

1 Month Return
+ 1.97 %
3 Month Return
-6.92 %
1 Year Return
-72.27 %
3 Year Return
+ 12.76 %
5 Year Return
0 %

Vaxcyte Inc Stock Fundamentals & Key Indicators

Check Vaxcyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2B

EPS (TTM)

-4.7686

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-698.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

1532700.00%

Vaxcyte Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vaxcyte Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$4.2BNANA0.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Vaxcyte Inc Stock including INR - Dollar returns

The Vaxcyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Vaxcyte Inc investment value today

Current value as on today

₹32,880

Returns

₹67,120

(-67.12%)

Returns from Vaxcyte Inc Stock

₹72,259 (-72.26%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Vaxcyte Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Vaxcyte Inc. Average target price of $106.33

Vaxcyte Inc Share Price Target

Get share price movements and forecasts by analysts on Vaxcyte Inc.

What analysts predicted

69.74%UPSIDE

Target Price

$106.33

Current Price

$32.18

Analyzed by

15 Analysts

Target

$106.33

Vaxcyte Inc target price $106.33, a slight upside of 69.74% compared to current price of $32.18. According to 15 analysts rating.

Vaxcyte Inc Stock's Interest Amongst Investors

Search interest for Vaxcyte Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Vaxcyte Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
14
-
-
-
-
-
-
Gross Profit
-2
-2
-2
11
-3
-3
-4
-
-
-4
Operating Income
-71
-87
-113
-121
-114
-152
-139
-162
-180
-226
EBITDA
-70
-87
-90
-177
-113
-152
-139
-52
-175
-161
Interest Expense
10
-
-
10
-
-
-
-
-
-
Depreciation
2
2
2
2
3
3
4
4
4
4
Income Before Tax
-60
-68
-92
-180
-95
-128
-103
-137
-140
-166
Income Tax Expense
-12
2
-2
14
-19
-
-4
-
-
-
Net Income
-48
-68
-92
-180
-95
-128
-103
-137
-140
-166
Net Profit Margin
0.00%
0.00%
0.00%
-1251.56%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-1
-1
-1
-1
-9
-75
-
Operating Income
-35
-54
-89
-103
-232
-468
-569
EBITDA
-28
-49
-87
-98
-214
-464
-448
Interest Expense
0
0
0
0
0
-
-
Depreciation
1
1
1
3
9
10
15
Income Before Tax
-29
-50
-89
-100
-223
-402
-463
Income Tax Expense
6
3
-1
0
16
-402
-
Net Income
-29
-53
-87
-100
-239
-402
-463
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-68
-92
-180
-95
-128
-103
-137
-140
-166
Operating Cash Flow
-62
-57
-128
-159
-121
-60
-111
-166
-121
Investing Cash Flow
-333
22
-13
-451
-80
-917
-557
123
77
Financing Cash Flow
546
48
2
818
110
1,515
4
0
2
Change in Cash
150
14
-147
214
-92
532
-662
-41
-40

Vaxcyte Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-29
-50
-89
-100
-223
-402
-463
Operating Cash Flow
-30
-47
-46
-121
-170
-296
-452
Investing Cash Flow
-1
-1
-1
-212
74
-773
-2,005
Financing Cash Flow
62
41
374
17
861
639
2,448
Change in Cash
29
-7
327
-316
765
-436
-9

Global Institutional Holdings in Vaxcyte Inc

Funds
Holdings
FMR Inc
9.64%
RA Capital Management, LLC
9.39%
Vanguard Group Inc
9.28%
HHG PLC
9.06%
BlackRock Inc
8.15%

Insights on Vaxcyte Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 112.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 148.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PCVX stock has moved down by -55.9%

About Vaxcyte Inc

sutrovax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. sutrovax’s lead product candidate is a pneumococcal conjugate vaccine (pcv) that is designed to prevent invasive pneumococcal disease (ipd) caused by streptococcus pneumoniae. sutrovax’s broad-spectrum pcv is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. the current mainstay vaccine only covers approximately 40% of the circulating strains causing ipd yet generates $6b in annual sales. sutrovax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum pcv compared head-to-head to current vaccines using well accepted immunological endpoints. in addition to its lead pcv product candidate, the company also has a promising early-stage pipeline addressing othe
OrganisationVaxcyte Inc
Headquarters825 Industrial Road, San Carlos, CA, United States, 94070
IndustryHealth Technology
CEOMr. Grant E. Pickering M.B.A.
E-voting on sharesClick here to vote

Key Management of Vaxcyte Inc

Name

Title

Ms. Elvia Cowan

Senior Vice President of Finance

Mr. Grant E. Pickering M.B.A.

Co-Founder, CEO & Director

Mr. Mikhail Eydelman J.D.

Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

Dr. Jeff Fairman Ph.D.

Co-Founder & VP of Research

Ms. Whitney Jones

Chief People Officer

Mr. Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Sam Iki

Senior Vice President of Project Management

Mr. Andrew L. Guggenhime M.B.A.

President & CFO

Mr. James Wassil M.B.A., M.S.

Executive VP & COO

Ms. Janet Graesser

Senior Vice President of Corporate Affairs

FAQs

What is Vaxcyte Inc share price today?

Vaxcyte Inc share price today is $32.18 as on at the close of the market. Vaxcyte Inc share today touched a day high of $32.88 and a low of $31.77.

What is the 52 week high and 52 week low for Vaxcyte Inc share?

Vaxcyte Inc share touched a 52 week high of $121.06 on and a 52 week low of $27.66 on . Vaxcyte Inc stock price today i.e. is closed at $32.18,which is 73.42% down from its 52 week high and 16.34% up from its 52 week low.

What is Vaxcyte Inc's market capitalisation today?

Vaxcyte Inc market capitalisation is $0.00T as on .

How to invest in Vaxcyte Inc Stock (PCVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vaxcyte Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vaxcyte Inc Shares that will get you 0.0466 shares as per Vaxcyte Inc share price of $32.18 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vaxcyte Inc Stock (PCVX) from India?

Indian investors can start investing in Vaxcyte Inc (PCVX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Vaxcyte Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vaxcyte Inc share’s latest price of $32.18 as on September 13, 2025 at 1:29 am IST, you will get 0.3108 shares of Vaxcyte Inc. Learn more about fractional shares .